Effects of Sacubitril/Valsartan Versus Irbesartan in Patients With Chronic Kidney Disease: A Randomized Double-Blind Trial
(2018)
Journal Article
Haynes, R., Judge, P. K., Staplin, N., Herrington, W. G., Storey, B. C., Bethel, A., Bowman, L., Brunskill, N., Cockwell, P., Hill, M., Kalra, P. A., McMurray, J. J. V., Taal, M., Wheeler, D. C., Landray, M. J., & Baigent, C. (2018). Effects of Sacubitril/Valsartan Versus Irbesartan in Patients With Chronic Kidney Disease: A Randomized Double-Blind Trial. Circulation, 138(15), 1505-1514. https://doi.org/10.1161/CIRCULATIONAHA.118.034818
Background: Sacubitril/valsartan reduces the risk of cardiovascular mortality among patients with heart failure with reduced ejection fraction, but its effects on kidney function and cardiac biomarkers in people with moderate-to-severe chronic kidney... Read More about Effects of Sacubitril/Valsartan Versus Irbesartan in Patients With Chronic Kidney Disease: A Randomized Double-Blind Trial.